Jenamazol

Clotrimazole, the active ingredient in Jenamazol, is an imidazole antifungal presented as a vaginal formulation for vaginal use. It treats vulvovaginal candidiasis, a common yeast infection affecting women.

GNH USA supplies Jenamazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jenamazol, an imidazole antifungal, is used to manage Candida infections affecting various mucosal and skin sites.

- Vulvovaginal candidiasis: relieves symptoms and eradicates Candida overgrowth in the vagina. - Cutaneous candidiasis: treats superficial skin infections caused by Candida species. - Oropharyngeal candidiasis: helps clear yeast infection of the mouth and throat.

Common Side Effects: - Local irritation: burning or stinging at the site of application. - Itching: mild pruritus in the vaginal area. - Discharge: increased vaginal secretions. - Dryness: sensation of dryness or tightness. - Redness: mild erythema around the application site. - Odor change: temporary alteration of vaginal odor.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Severe skin rash: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Liver toxicity: rare signs of hepatitis such as jaundice. - Systemic hypersensitivity: fever, chills, or malaise. - Persistent vaginal ulceration. - Unexplained bleeding or severe irritation.

Before using Jenamazol, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Allergy: avoid if known hypersensitivity to clotrimazole or other imidazoles. - Concurrent vaginal products: do not use with other intravaginal medications unless directed. - Immunocompromised patients: monitor closely for treatment failure. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Clotrimazole may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic azole antifungals: increased risk of additive toxicity. - Warfarin: potential enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in hormonal efficacy. - Topical steroids: may diminish antifungal activity. - Antacids: could affect absorption of concurrently administered oral agents. - Other intravaginal medications: may alter local drug concentration.